$Aeglea生物制药(AGLE)$ 8-K - Current report Filed: 2019-02-07 AccNo: 0001193125-19-029935 Size: 410 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接